HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroki Nagase Selected Research

Immune Checkpoint Inhibitors

1/2022Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics.
10/2020Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroki Nagase Research Topics

Disease

51Neoplasms (Cancer)
05/2022 - 01/2002
13Neuroblastoma
02/2022 - 01/2012
11Neoplasm Metastasis (Metastasis)
05/2022 - 12/2009
9Carcinogenesis
01/2021 - 06/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2012
5Osteosarcoma (Osteogenic Sarcoma)
07/2021 - 01/2010
4Adenocarcinoma
05/2022 - 03/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2019 - 10/2004
4Hepatocellular Carcinoma (Hepatoma)
01/2015 - 01/2005
3Inflammation (Inflammations)
01/2020 - 03/2009
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2016
3Cicatrix (Scar)
01/2015 - 03/2010
3Hyperplasia
03/2009 - 01/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2021 - 12/2009
2Body Weight (Weight, Body)
01/2021 - 05/2014
2Colonic Neoplasms (Colon Cancer)
04/2015 - 09/2007
2Melanoma (Melanoma, Malignant)
01/2015 - 08/2010
2Brain Neoplasms (Brain Tumor)
01/2015 - 01/2010
2Hypertrophic Cicatrix (Hypertrophic Scar)
01/2015 - 10/2011
2Burns
01/2015 - 03/2010
2Squamous Cell Carcinoma of Head and Neck
09/2012 - 10/2010
2Skin Neoplasms (Skin Cancer)
07/2010 - 06/2007
2Glioma (Gliomas)
01/2010 - 12/2009
2Ovarian Neoplasms (Ovarian Cancer)
12/2009 - 10/2004
2Carcinoma (Carcinomatosis)
08/2003 - 01/2002
1Chromosome Aberrations (Chromosome Abnormalities)
12/2021
1Lewis Lung Carcinoma
10/2021
1Obesity
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Esophageal Squamous Cell Carcinoma
01/2021
1Liver Neoplasms (Liver Cancer)
06/2020
1Alcoholism (Alcohol Abuse)
01/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2019

Drug/Important Bio-Agent (IBA)

26Nylons (Nylon)IBA
04/2022 - 07/2008
17DNA (Deoxyribonucleic Acid)IBA
12/2021 - 08/2003
15imidazoleIBA
04/2022 - 03/2010
15PyrrolesIBA
04/2022 - 03/2010
9Proteins (Proteins, Gene)FDA Link
07/2020 - 02/2005
8Mitochondrial DNA (mtDNA)IBA
04/2022 - 01/2010
8Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2012
7Messenger RNA (mRNA)IBA
02/2022 - 07/2008
6Pharmaceutical PreparationsIBA
04/2022 - 01/2020
5Biological ProductsIBA
05/2022 - 06/2007
3RNA (Ribonucleic Acid)IBA
05/2022 - 01/2020
3tetraphenylporphine sulfonate (TPPS)IBA
04/2022 - 06/2021
3Transforming Growth Factors (Transforming Growth Factor)IBA
06/2020 - 03/2010
31-methylimidazoleIBA
01/2020 - 10/2015
3Small Interfering RNA (siRNA)IBA
01/2020 - 12/2009
3Phosphotransferases (Kinase)IBA
07/2019 - 05/2005
3Acetates (Acetic Acid Esters)FDA Link
11/2018 - 06/2007
3Transcription Factors (Transcription Factor)IBA
04/2017 - 01/2013
3Cisplatin (Platino)FDA LinkGeneric
04/2017 - 10/2010
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014 - 03/2010
3hydrogen sulfite (bisulfite)IBA
01/2010 - 09/2007
3Trefoil Factor-3IBA
07/2007 - 01/2005
2triphenylphosphoniumIBA
04/2022 - 12/2021
2Immune Checkpoint InhibitorsIBA
01/2022 - 10/2020
2Histones (Histone)IBA
12/2021 - 08/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 06/2012
2NucleotidesIBA
10/2021 - 11/2017
2NADH DehydrogenaseIBA
01/2021 - 11/2017
2AntigensIBA
01/2021 - 02/2005
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 08/2010
2N-methylpyrroleIBA
01/2020 - 10/2015
2PF 00477736IBA
01/2020 - 07/2019
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2019 - 05/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2017 - 01/2015
2Leucine (L-Leucine)FDA Link
09/2016 - 10/2014
2Codon (Codons)IBA
01/2016 - 10/2015
2LipidsIBA
05/2014 - 03/2009
2Matrix Metalloproteinases (MMPs)IBA
01/2014 - 03/2010
2S100 Calcium-Binding Protein A4IBA
12/2012 - 12/2009
2Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2010 - 03/2009
2Trefoil FactorsIBA
02/2005 - 01/2005
1SenotherapeuticsIBA
04/2022
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1IntegrinsIBA
01/2022
1Ferritins (Ferritin)IBA
12/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2021
1Adenosine Triphosphate (ATP)IBA
12/2021
1palbociclibIBA
07/2021
1Adiponectin ReceptorsIBA
01/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2021
1LeptinIBA
01/2021
1AdipoRonIBA
01/2021
1SolutionsIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Trace Elements (Biometals)IBA
01/2021
1ChemokinesIBA
01/2020
1Interleukin-33IBA
01/2020
1Disulfiram (Antabuse)FDA Link
01/2020
1CytokinesIBA
01/2020
1Orphan Nuclear ReceptorsIBA
06/2019
1Member 3 Group A Nuclear Receptor Subfamily 4IBA
06/2019
1EphA1 Receptor (Eph Receptor)IBA
04/2019

Therapy/Procedure

6Therapeutics
04/2022 - 12/2009
3Drug Therapy (Chemotherapy)
07/2021 - 09/2008
1Fat-Restricted Diet (Diet, Fat Restricted)
01/2021